SOD1 and neuroblastoma: NAC administration can reduce oxidative damage and mitochondrial dysregulation in human neuroblastoma cells (SH-SY5Y) with the G93A-SOD1 mutation, and delay the beginning of motor injuries and enhance survival in G93A-SOD1 mutated mice [431,432].